Stomach ulcers are caused by bacteria, not stress or spicy food
For decades, physicians blamed peptic ulcers on emotional stress, acid-heavy diets, and spicy foods. In the 1980s, Australian researchers Robin Warren and Barry Marshall discovered the real culprit: Helicobacter pylori, a spiral bacterium adapted to survive harsh gastric acid. When the medical community dismissed their findings, Marshall famously swallowed a broth of the bacteria to induce acute gastritis and cured himself with antibiotics, earning the pair a Nobel Prize in 2005.
The Long-Standing Dogma of Acid and Stress
For much of the twentieth century, peptic ulcer disease was categorized as a classic psychosomatic disorder. Medical consensus held that emotional stress, demanding work environments, heavy smoking, and spicy or acidic foods triggered the stomach to overproduce gastric acid. This excess acid was believed to burn through the stomach's protective lining, creating painful open sores in the stomach wall or the duodenum. Because acid was seen as the primary cause, the medical maxim was simple: without acid, there could be no ulcer. Patients were regularly instructed to manage their stress, follow bland diets, and consume dairy products to coat their stomach linings.
When behavioral modifications failed, treatments focused exclusively on suppressing acid or physically modifying the digestive tract. Antacids and early acid-blocking drugs offered symptomatic relief, but ulcers almost invariably returned once the medications were discontinued. In severe cases involving recurrent bleeding, perforation, or gastric obstruction, patients underwent major surgeries. Procedures such as partial gastrectomies or vagotomies—the surgical severing of the vagus nerve to reduce acid stimulation—carried lasting side effects. The medical community accepted this cycle of recurrence and surgery because human gastric acid was thought to render the stomach completely sterile, precluding any infectious cause.
An Unexpected Finding in Perth
The prevailing view began to unravel in the late 1970s and early 1980s through the work of Robin Warren, a pathologist at Royal Perth Hospital in Australia. While examining stomach biopsy specimens, Warren repeatedly observed small, curved bacteria colonizing the lower region of the stomach, known as the antrum. Medical doctrine had long dismissed isolated reports of bacteria in stomach tissue as harmless contaminants or post-mortem artifacts. However, Warren noted a critical detail: the presence of these bacteria consistently coincided with histological evidence of tissue inflammation, or gastritis, in the surrounding mucosa.
In 1981, Barry Marshall joined Warren to examine the clinical significance of these organisms, initiating a study of one hundred patient biopsies. Initial laboratory attempts to culture the organism repeatedly failed because culture plates were routinely discarded after forty-eight hours without visible growth. In the spring of 1982, plates were left incubating over an extended Easter holiday weekend. By the fifth day, distinct bacterial colonies emerged. The organism was identified as a Gram-negative, spiral-shaped bacterium, later named Helicobacter pylori. Warren and Marshall found the microbe was present in almost all patients with duodenal ulcers and the vast majority of those with gastric ulcers.
The Self-Experiment That Challenged the Field
Despite presenting their findings, Warren and Marshall faced widespread resistance from the gastroenterology community. Most physicians found it implausible that a bacterium could survive gastric acid, let alone cause a common chronic disease. Furthermore, animal inoculation models consistently failed to reproduce the infection, preventing the researchers from satisfying Koch's postulates—the standard scientific criteria required to prove that a specific micro-organism causes a specific disease. Unable to demonstrate that the bacterium was an active pathogen rather than a harmless opportunist living in already damaged tissue, their conclusions were widely dismissed.
Faced with this impasse, Marshall performed a self-experiment in 1984. After undergoing a baseline endoscopy to confirm his stomach was healthy, he obtained a culture of Helicobacter pylori from an ulcer patient, mixed it into a liquid suspension, and drank it. Several days later, he developed nausea, vomiting, foul breath, and fatigue. A follow-up endoscopy and biopsy confirmed widespread, acute gastritis and dense colonization of his stomach lining by the bacteria. Marshall then took a course of antibiotics, successfully eliminating the infection and reversing the inflammation. This demonstrated that the bacterium could infect a healthy stomach and directly initiate disease.
How the Bacterium Survives Gastric Acid
The stomach is an inhospitable environment designed to break down dietary proteins and destroy swallowed pathogens using concentrated hydrochloric acid. Helicobacter pylori survives in this acidic space through specialized enzymatic and physiological adaptations. Central to its survival is the production of abundant quantities of the enzyme urease. Urease metabolizes urea, a chemical naturally present in gastric juices, converting it into carbon dioxide and ammonia. The basic ammonia molecules act as a buffer, neutralizing the surrounding gastric acid and enveloping the bacterium in a protective, neutral microenvironment.
In addition to chemical protection, the bacterium employs physical motility to escape the bulk acid in the stomach lumen. Helicobacter pylori possesses a spiral shape and multiple unipolar flagella that enable it to bore through the viscous layer of protective mucus covering the stomach lining. By migrating beneath this mucus blanket, the bacterium reaches the neutral layer adjacent to the gastric epithelial cells, where acid levels are substantially lower. It then utilizes specialized surface adhesins to anchor itself directly to host epithelial cells, ensuring it is not expelled by the muscular contractions of stomach emptying.
From Infection to Tissue Destruction
Once anchored to the stomach wall, Helicobacter pylori induces a persistent immune response that damages host tissue. The bacterium releases inflammatory molecules and antigenic proteins that attract white blood cells, such as neutrophils and lymphocytes, to the gastric mucosa. However, the immune cells cannot easily clear the bacteria living within the mucus layer. Instead, the persistent immune activation leads to sustained inflammation, known as chronic gastritis. The host’s own inflammatory mediators and reactive oxygen species gradually degrade the mucosal tissue, weakening the protective barrier.
Tissue damage is further accelerated by specific bacterial toxins. Strains carrying the cytotoxin-associated gene A (CagA) inject the CagA protein directly into host epithelial cells using a needle-like type IV secretion system, disrupting normal cellular structure, signaling, and barrier integrity. Another key toxin, vacuolating cytotoxin A (VacA), causes cellular vacuolation, pore formation, and cell death. As epithelial cells die and the mucus shield is breached, the stomach's own digestive acid and enzymes reach the sensitive underlying tissues. This auto-digestion eats away at the gastric or duodenal wall, culminating in the formation of a peptic ulcer.
Broader Risks and the Modern Cure
Beyond localized ulceration, long-term Helicobacter pylori infection carries serious oncological consequences. While most infected individuals remain asymptomatic, chronic infection is recognized as the leading risk factor for gastric cancer, including gastric adenocarcinoma and gastric mucosal-associated lymphoid tissue (MALT) lymphoma. Decades of chronic active gastritis can lead to gastric atrophy and intestinal metaplasia, a cascade of tissue transformation that may advance to malignancy. In low-grade gastric MALT lymphomas, the relationship is so direct that antibiotic eradication of the bacterium alone frequently causes the tumor to regress completely.
The confirmation that peptic ulcers are infectious transformed clinical practice across the globe. Rather than subjecting patients to years of acid suppression, restrictive lifestyle regimens, and hazardous surgeries, doctors began treating ulcers with short courses of combination antimicrobial therapy. Modern regimens combine a proton pump inhibitor, which suppresses acid to aid healing, with two or more antibiotics, such as amoxicillin, clarithromycin, or metronidazole. Eradicating the bacterium cures the underlying infection, heals active ulcers, and prevents recurrence, earning Warren and Marshall the 2005 Nobel Prize in Physiology or Medicine.
Key takeaways
•Peptic ulcers and chronic gastritis are primarily caused by bacterial infection with Helicobacter pylori, not emotional stress or spicy food.
•Helicobacter pylori survives the stomach's hydrochloric acid by using the enzyme urease to convert urea into neutralizing ammonia, creating a protective microenvironment.
•Barry Marshall drank a broth of the bacteria to overcome medical skepticism, proving the microbe directly caused acute gastritis, which he then cured with antibiotics.
•Eradicating the bacterium with combination antibiotic and acid-suppressing therapy cures peptic ulcers and significantly reduces the risk of recurrence and gastric cancer.